2'-fluorothymidine has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A | 1 |
| Anderson, LW; Brown-Proctor, C; Collins, JM; Egorin, MJ; Eiseman, JL; Hamburger, DR; Joseph, E; Kinahan, PE; Klecker, RW; Mathis, CA; Pan, SS | 1 |
2 other study(ies) available for 2'-fluorothymidine and Colorectal Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution | 2004 |
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
Topics: Animals; Arabinofuranosyluracil; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; HT29 Cells; Humans; Mice; Mice, SCID; Positron-Emission Tomography; Thymidylate Synthase; Time Factors; Tissue Distribution; Tritium; Xenograft Model Antitumor Assays | 2004 |